Discovery of the Selective Protein Kinase C-θ Kinase Inhibitor, CC-90005

被引:4
|
作者
Papa, Patrick [1 ]
Whitefield, Brandon [1 ]
Mortensen, Deborah S. [1 ]
Cashion, Dan [1 ]
Huang, Dehua [1 ]
Torres, Eduardo [1 ]
Parnes, Jason [1 ]
Sapienza, John [1 ]
Hansen, Joshua [1 ]
Correa, Matthew [1 ]
Delgado, Mercedes [1 ]
Harris, Roy [1 ]
Hegde, Sayee [1 ]
Norris, Stephen [1 ]
Bahmanyar, Sogole [1 ]
Plantevin-Krenitsky, Veronique [1 ]
Liu, Zheng [1 ]
Leftheris, Katerina [1 ]
Kulkarni, Ashutosh [1 ]
Bennett, Brydon [1 ]
Hur, Eun Mi [2 ]
Ringheim, Garth [2 ]
Khambatta, Godrej [1 ]
Chan, Henry [1 ]
Muir, Jeffrey [1 ]
Blease, Kate [1 ]
Burnett, Kelven [1 ]
LeBrun, Laurie [1 ]
Morrison, Lisa [1 ]
Celeridad, Maria [1 ]
Khattri, Roli [1 ]
Cathers, Brian E. [1 ]
机构
[1] Bristol Myers Squibb, San Diego, CA 92121 USA
[2] Bristol Myers Squibb, Summit, NJ 07901 USA
关键词
KAPPA-B ACTIVATION; PKC-THETA; OPTIMIZATION; AUTOIMMUNITY; AEB071; CELLS; MICE;
D O I
10.1021/acs.jmedchem.1c00388
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The PKC-theta isoform of protein kinase C is selectively expressed in T lymphocytes and plays an important role in the T cell antigen receptor (TCR)-triggered activation of mature T cells, T cell proliferation, and the subsequent release of cytokines such as interleukin-2 (IL-2). Herein, we report the synthesis and structure-activity relationship (SAR) of a novel series of PKC-theta inhibitors. Through a combination of structure-guided design and exploratory SAR, suitable replacements for the basic C4 amine of the original lead (3) were identified. Property-guided design enabled the identification of appropriately substituted C2 groups to afford potent analogs with metabolic stability and permeability to support in vivo testing. With exquisite general kinase selectivity, cellular inhibition of T cell activation as assessed by IL-2 expression, a favorable safety profile, and demonstrated in vivo efficacy in models of acute and chronic T cell activation with oral dosing, CC-90005 (57) was selected for clinical development.
引用
收藏
页码:11886 / 11903
页数:18
相关论文
共 50 条
  • [31] Dual Inhibition of Classical Protein Kinase C-α and Protein Kinase C-β Isoforms Protects Against Experimental Murine Diabetic Nephropathy
    Menne, Jan
    Shushakova, Nelli
    Bartels, Janina
    Kiyan, Yulia
    Laudeley, Robert
    Haller, Hermann
    Park, Joon-Keun
    Meier, Matthias
    DIABETES, 2013, 62 (04) : 1167 - 1174
  • [32] INVOLVEMENT OF CPI-17 AND ZIPPER-INTERACTING PROTEIN KINASE IN THE REGULATION OF PROTEIN KINASE C-α, PROTEIN KINASE C-ε ON VASCULAR CALCIUM SENSITIVITY AFTER HEMORRHAGIC SHOCK
    Xu, Jing
    Yang, Guangming
    Li, Tao
    Ming, Jia
    Liu, Liangming
    SHOCK, 2010, 33 (01): : 49 - 55
  • [33] Discovery of Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor CC-223
    Mortensen, Deborah S.
    Perrin-Ninkovic, Sophie M.
    Shevlin, Graziella
    Zhao, Jingjing
    Packard, Garrick
    Bahmanyar, Sogole
    Correa, Matthew
    Elsner, Jan
    Harris, Roy
    Lee, Branden G. S.
    Papa, Patrick
    Parnes, Jason S.
    Riggs, Jennifer R.
    Sapienza, John
    Tehrani, Lida
    Whitefield, Brandon
    Apuy, Julius
    Bisonette, Rene R.
    Gamez, James C.
    Hickman, Matt
    Khambatta, Godrej
    Leisten, Jim
    Peng, Sophie X.
    Richardson, Samantha J.
    Gathers, Brian E.
    Callan, Stacie S.
    Moghaddam, Mehran F.
    Raymon, Heather K.
    Worland, Peter
    Narla, Rama Krishna
    Fultz, Kimberly E.
    Sankar, Sabita
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (13) : 5323 - 5333
  • [34] Discovery and Optimization of 1,3,5-Trisubstituted Pyrazolines as Potent and Highly Selective Allosteric Inhibitors of Protein Kinase C-ζ
    Abdel-Halim, Mohammad
    Diesel, Britta
    Kiemer, Alexandra K.
    Abadi, Ashraf H.
    Hartmann, Rolf W.
    Engel, Matthias
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (15) : 6513 - 6530
  • [35] Discovery of a Highly Selective STK16 Kinase Inhibitor
    Liu, Feiyang
    Wang, Jinhua
    Yang, Xingxing
    Li, Binhua
    Wu, Hong
    Qi, Shuang
    Chen, Cheng
    Liu, Xiaochuan.
    Yu, Kailin
    Wang, Wenchao
    Zhao, Zheng
    Wang, Aoli
    Chen, Yongfei
    Wang, Li
    Gray, Nathanael S.
    Liu, Jing
    Zhang, Xin
    Liu, Qingsong
    ACS CHEMICAL BIOLOGY, 2016, 11 (06) : 1537 - 1543
  • [36] Selective ceramide-binding to protein kinase C-α and -δ isoenzymes in renal mesangial cells
    Huwiler, A
    Brunner, J
    Fabbro, D
    Pfeilschifter, J
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (04) : R778 - R778
  • [37] ORAL, ANTIINFLAMMATORY ACTIVITY OF A POTENT, SELECTIVE, PROTEIN-KINASE-C INHIBITOR
    MULQUEEN, MJ
    BRADSHAW, D
    DAVIS, PD
    ELLIOTT, L
    GRIFFITHS, TA
    HILL, CH
    KUMAR, H
    LAWTON, G
    NIXON, JS
    SEDGWICK, AD
    WADSWORTH, J
    WESTMACOTT, D
    WILKINSON, SE
    AGENTS AND ACTIONS, 1992, 37 (1-2): : 85 - 89
  • [38] Synthesis of staurosporine analog as potential selective inhibitor of protein kinase C.
    Zhao, YP
    Yue, XJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U10 - U10
  • [39] Effect of ghrelin on protein kinase C-ε and protein Kinase C-δ gene expression in the pulmonary arterial smooth muscles of chronic hypoxic rats
    M. R. Alipour
    M. R. Aliparasti
    R. Keyhanmanesh
    S. Almasi
    M. Halimi
    K. Ansarin
    H. Feizi
    Journal of Endocrinological Investigation, 2011, 34 : e369 - e373
  • [40] Effect of ghrelin on protein kinase C-ε and protein kinase C-δ gene expression in the pulmonary arterial smooth muscles of chronic hypoxic rats
    Alipour, M. R.
    Aliparasti, M. R.
    Keyhanmanesh, R.
    Almasi, S.
    Halimi, M.
    Ansarin, K.
    Feizi, H.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2011, 34 (10) : E369 - E373